List of signals discussed at PRAC since September 2012
Submitted by Anonymous (not verified) on 22 June 2026 - 15:03
List of signals discussed at PRAC since September 2012
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 38, Status: Authorised
Submitted by Anonymous (not verified) on 22 June 2026 - 14:33
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 38, Status: Authorised
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 32, Status: Authorised
Submitted by Anonymous (not verified) on 22 June 2026 - 14:25
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 32, Status: Authorised
Shortage prevention plan (SPP) workshop, Online, from 22 June 2026, 10:30 (CEST) to 22 June 2026, 12:30 (CEST)
Submitted by Anonymous (not verified) on 22 June 2026 - 13:28
Shortage prevention plan (SPP) workshop, Online, from 22 June 2026, 10:30 (CEST) to 22 June 2026, 12:30 (CEST)
Evrysdi
Submitted by Anonymous (not verified) on 22 June 2026 - 12:37
Evrysdi
Website outages and upgrades
Submitted by Anonymous (not verified) on 22 June 2026 - 10:50
Website outages and upgrades
Human medicines European public assessment report (EPAR): Winrevair, sotatercept, Date of authorisation: 22/08/2024, Revision: 5, Status: Authorised
Submitted by Anonymous (not verified) on 19 June 2026 - 15:23
Human medicines European public assessment report (EPAR): Winrevair, sotatercept, Date of authorisation: 22/08/2024, Revision: 5, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Scovella, velagliflozin, Status: Opinion
Submitted by Anonymous (not verified) on 19 June 2026 - 14:30
Veterinary medicines European public assessment report (EPAR): Scovella, velagliflozin, Status: Opinion
Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCPFeLV, feline calicivirosis, feline rhinotracheitis, feline panleucopenia (live) and feline leukemia (RNA replicon particle) vaccine, Status: Opinion
Submitted by Anonymous (not verified) on 19 June 2026 - 14:30
Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCPFeLV, feline calicivirosis, feline rhinotracheitis, feline panleucopenia (live) and feline leukemia (RNA replicon particle) vaccine, Status: Opinion
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 June 2026
Submitted by Anonymous (not verified) on 19 June 2026 - 14:30
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 June 2026